 |
|
|
|
enfuvirtide |
|
Detailed Prescribing Information |
|
October 2005 |
|
Fuzeon = enfuvirtide = T-20 |
|
| Forms Available | 90 mg vials |
| Dosing |
90 mg injected SQ q12h Drug reconstitution takes approximately 20 minutes once or twice a day. |
| Adverse Effects |
Local reactions
to injections: erythema, tenderness, induration are frequent and minimized by
good injection technique, rubbing the injection site for several minutes after
injection. Also hypersensitivity rash, cellulitis, and a possible minimal predisposition to bacterial pneumonia. |
| Interactions | None known |
| Suggested lab follow-up |
None specific to this drug (see administration
protocol above) HIV viral load at 2-4 weeks after initiation and monthly until fully suppressed |
| Warning | Possible minimal increase in bacterial pneumonia noted during the approval phase of this drug. |
| Complete prescribing information | http://www.fuzeon.com |
| Click HERE for Antiretroviral Therapy Summary and Recommendations |
| Links to Antiretroviral Sections (click on anything) |
| Nucleoside & Nucleotide Reverse Transcriptase Inhibitors (NRTI) |
| AZT | ddC | ddI | d4T | 3TC | ABC | FTC | TDF | Combivir | Trizivir | Epzicom | Truvada |
| Nonnucleoside Reverse Transcriptase Inhibitors (NNRTI) |
| efavirenz | nevirapine | delavirdine |
| Protease Inhibitors (PI) | Boosted Protease Inhibitors |
| saquinavir | indinavir | ritonavir | nelfinavir | amprenavir | lopinavir + ritonavir | atazanavir | fosamprenavir | tipranavir |
| Fusion Inhibitors |
| enfuvirtide |
Updated 2.24.2005
